Insilico Medicine to Present Phase 1 ISM6331 Results at ESMO 2026
Insilico Medicine has announced that first-in-human Phase 1 data for ISM6331, an AI-designed pan-TEAD inhibitor, has been accepted for a ...
Insilico Medicine has announced that first-in-human Phase 1 data for ISM6331, an AI-designed pan-TEAD inhibitor, has been accepted for a ...
At last, astronomers have obtained strong, direct evidence that Betelgeuse—the iconic red supergiant in Orion—is accompanied by a faint stellar ...
Ultra-processed food intake may influence a child’s health even before conception, according to a study tracking diet and newborn body ...
A new pan-European study is pulling the spotlight from drug chemistry to clinician psychology—showing that whether healthcare professionals prescribe novel, ...
Popular children’s biographies that celebrate scientists may be doing more harm than good, according to new research from the University ...
Cancer outcomes are shaped not just by malignant cells, but by the spatial ecosystem around them—immune neighborhoods, vasculature, and stromal ...
A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...
A new viral wave of clinical curiosity is building around a study published in Pediatric Research on 28 July 2026, ...
A new study reports that hospitals can sustain lasting changes to how neonatal platelet transfusions are used after adopting an ...
A new study published in Communications Earth & Environment reports a physics-guided deep learning system designed to forecast wind speed ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine